Bank of Montreal
DTIL icon

Bank of Montreal’s Precision BioSciences DTIL Stock Holding History

Bank of Montreal’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,953
Closed -$355K – 3872
2022
Q4 		$355K Buy
+9,953
New +$393K ﹤0.01% 2813
2021
Q2 		– Sell
-69
Closed -$19K – 3994
2021
Q1 		$19K Sell
69
-180
-72% -$63K ﹤0.01% 4078
2020
Q4 		$72K Buy
249
+168
+207% +$41.2K ﹤0.01% 3756
2020
Q3 		$16K Sell
81
-41
-34% -$8.15K ﹤0.01% 3919
2020
Q2 		$30K Buy
+122
New +$26.7K ﹤0.01% 3663
2020
Q1 		– Sell
-157
Closed -$66K – 4242
2019
Q4 		$66K Buy
157
+130
+481% +$40.8K ﹤0.01% 3702
2019
Q3 		$7K Buy
27
+1
+4% +$325 ﹤0.01% 4500
2019
Q2 		$10K Buy
+26
New +$10.5K ﹤0.01% 4518

Other funds holding DTIL

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of Montreal's DTIL Position: Q1 2023 in Review

Bank of Montreal sold out of Precision BioSciences (DTIL) in Q1 2023, closing a stake of 9,953 shares — an estimated $355K sold.

Bank of Montreal first reported a position in DTIL in Q2 2019 and held it in 8 quarters. The position peaked at $355K in Q4 2022. 86 funds tracked by Wall St. Rank hold DTIL as of Q1 2023.

  • Bank of Montreal reported no remaining Precision BioSciences position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 9,953 Precision BioSciences shares in Q1 2023, an estimated $355K.
  • Bank of Montreal first reported a position in Precision BioSciences in Q2 2019 and held it in 8 quarters.
  • Bank of Montreal's Precision BioSciences position peaked at $355K in Q4 2022.
  • 86 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.